|
Website:
http://www.novartis.com
Phone: +41 61 324 1111 |
Address:
CH-4002 Basel
4002 Basel, |
Company Description
Novartis AG. The Group's principal activity is the development and manufacture of pharmaceuticals and nutritional products. The Group operates through four divisions; Pharmaceuticals, Consumer Health, Sandoz & Vaccines & Diagnostics. Pharmaceuticals Division includes drugs for use in transplantations, central nervous system disorders, cardiovascular, endocrine and respiratory diseases, dermatology, oncology, hematology and rheumatism and bone and hormone replacement therapy. Consumer Health Division includes Generics/OTC and sells copies of prescription medicines no longer under patent protection; medical nutrition and self-medication. Sandoz Division: Manufactures, distributes and sells generic pharmaceutical products and substances no longer subject to patent protection. Vaccines & Diagnostics Division provides innovative vaccines and a range of conventional products to combat viral and bacterial diseases. In 2006, the Group acquired Chiron Corporation & NeuTec Pharma plc. Pharmaceuticals accounted for 63% of 2006 revenues, Consumer Health, 18%, Sandoz, 17% & Vaccines & Diagnostics, 2%
Key People
| Chairman, President & Chief Executive | Dr. Daniel Vasella |
| Chief Financial Officer | Raymund Breu |
| Vice Chairman | Prof. Ulrich Lehner |
| Vice Chairman | Hans-Joerg Rudloff |
| Secretary | Monika Matti |
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
N
Novartis AG
Discovers, develops, manufactures and markets arthritis, inflammation, bone, cardiovascular, metabolic, dermatology, hematology, neuroscience, and oncology drugs.
www.novartis.com
Discovers, develops, manufactures and markets arthritis, inflammation, bone, cardiovascular, metabolic, dermatology, hematology, neuroscience, and oncology drugs.
www.novartis.com
Breaking News
USA Today - 1 hour ago
NEW YORK (AP) ? Basketball great Kareem Abdul-Jabbar is being treated for a rare form of leukemia, and he said his prognosis is encouraging. The NBA's all-time leading scorer and six-time league MVP was diagnosed last December with chronic myeloid ...
SI.com - 3 hours ago
Kareem Abdul-Jabbar is being treated for a rare form of leukemia, and the basketball great said his prognosis is encouraging. The NBA's all-time leading scorer was diagnosed last December with chronic myeloid leukemia, he told The Associated Press on ...
Reuters - 8 hours ago
ZURICH, Nov 10 (Reuters) - Swiss shares were seen opening higher on Tuesday following other global equities markets on hopes government economic stimulus measures will continue. The blue chip SMI index .SSMI was expected to open 25 points higher at 6,411 ...
Reuters UK - 9 hours ago
ZURICH, Nov 10 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Tuesday. UBS (UBSN.VX) Robert McCann, the new head of the U.S. wealth management unit of UBS AG, hired a team of former bankers of Merrill Lynch to ...
Forbes.com - 9 hours ago
ZURICH, Nov 10 (Reuters) - Novartis AG: * Buys majority stake in Chinese h1n1 business for $125 million ((Zurich Newsroom, ...
Pfizer and Wyeth
Pfizer & Wyeth Are Joining Together to Work for a Healthier World.
www.Pfizer.com/Pfizer&Wyeth
Pfizer & Wyeth Are Joining Together to Work for a Healthier World.
www.Pfizer.com/Pfizer&Wyeth
Pfizer Pharmaceutical
Morningstar provides a Free Report: "Healthcare Sector and the Economy"
healthcare.morningstar.com
Morningstar provides a Free Report: "Healthcare Sector and the Economy"
healthcare.morningstar.com
